Prelude Capital Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Prelude Capital Management’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-25,572	Closed	-$153K	–	2010
2017 Q3	$153K	Buy	+25,572	New	+$66.3K	0.01%	734
2016 Q4	–	Sell	-2,000	Closed	-$16K	–	2009
2016 Q3	$16K	Sell	2,000 -1,000	-33%	-$7.23K	﹤0.01%	1374
2016 Q2	$18K	Buy	+3,000	New	+$22.8K	﹤0.01%	1316

Prelude Capital Management's DMTX Position: Q4 2017 in Review

Prelude Capital Management sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 25,572 shares — an estimated $153K sold.

Prelude Capital Management first reported a position in DMTX in Q2 2016 and held it in 3 quarters. The position peaked at $153K in Q3 2017. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

Prelude Capital Management reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
Prelude Capital Management sold 25,572 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $153K.
Prelude Capital Management first reported a position in Dimension Therapeutics, Inc in Q2 2016 and held it in 3 quarters.
Prelude Capital Management's Dimension Therapeutics, Inc position peaked at $153K in Q3 2017.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on Prelude Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.